Small CGG repeat expansion alleles of FMR1 gene are associated with parkinsonism

D Z Loesch1, M S Khaniani, H R Slater

  • 1School of Psychological Science, La Trobe University, Melbourne/Bundoora, Victoria, Australia. d.loesch@latrobe.edu.au

Clinical Genetics
|October 3, 2009
PubMed

Insights

Fragile X-associated tremor/ataxia syndrome (FXTAS) is linked to FMR1 gene premutation alleles. This study found that both premutation and smaller "grey zone" FMR1 alleles are more common in males with parkinsonism, suggesting a role in the condition's development.

Area of Science:

  • Neurogenetics
  • Movement Disorders

Background:

  • Fragile X-associated tremor/ataxia syndrome (FXTAS) is associated with FMR1 gene premutation alleles (55-200 CGG repeats).
  • Neurological issues in FXTAS are linked to toxic gain-of-function from excessive FMR1 messenger RNA (mRNA).
  • Elevated FMR1 mRNA levels are also observed in carriers of smaller expansion
  • grey zone
  • alleles (40-54 CGGs).

Purpose of the Study:

  • To investigate the potential role of FMR1 premutation and grey zone alleles in the etiology of parkinsonism.
  • To determine if these alleles are more prevalent in males diagnosed with idiopathic Parkinson's disease or other parkinsonian disorders.

Main Methods:

  • Screening of 228 Australian males with parkinsonism for FMR1 premutation and grey zone alleles.
  • Comparison of allele frequencies in cases against a population-based control group (578 Tasmanian male newborns).
  • Statistical analysis using Fisher's exact test and calculation of odds ratios (OR) with 95% confidence intervals (CI).

Main Results:

  • A significant excess of FMR1 premutation carriers was found in the parkinsonism group (p = 0.006).
  • A more than twofold increase in grey zone allele carriers was observed in the combined case sample (OR = 2.36, 95% CI: 1.20-4.63).
  • This increase in grey zone carriers was also significant in Tasmanian cases only (OR = 2.33, 95% CI: 1.06-5.13).

Conclusions:

  • FMR1 premutation alleles are significantly associated with parkinsonism.
  • FMR1 grey zone alleles may also contribute to the development of parkinsonism.
  • These findings suggest a potential genetic link between FMR1 expansions and movement disorders like Parkinson's disease.

Related Concept Videos

Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...